RS
Ruhani Singla
About Ruhani Singla
Data last updated:
Ruhani Singla is a Director at Tyzpure Lifesciences Private Limited (since 2024), Director at Kyzna Pharma Private Limited (since 2026) and Director at Lyfine Pharma Private Limited (since 2024). The companies operate in Chemicals. The largest current company by reported revenue is Tyzpure Lifesciences Private Limited at ₹2.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tyzpure Lifesciences Private Limited U24299HR2021PTC092667 | Director | 05 Mar 2024 | 2021 | ₹2.26 Cr (FY 2025) | Active |
 Kyzna Pharma Private Limited U46497HR2026PTC142105 | Director | 20 Feb 2026 | 2026 | Active | |
| Lyfine Pharma Private Limited U46497HR2024PTC120524 | Director | 07 Apr 2024 | 2024 | Active |
Board colleagues of Ruhani Singla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dharam Vir Singla | 09052826 | Tyzpure Lifesciences Private Limited | Director |
| Shruti Jaryal | 11559815 | Kyzna Pharma Private Limited | Director |
| Vivek Singla | 07660514 | Lyfine Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ruhani Singla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruhani Singla
Ruhani Singla currently holds 3 directorships: Tyzpure Lifesciences Private Limited (Director, since 05 Mar 2024, revenue ₹2.26 Cr (FY 2025)); Kyzna Pharma Private Limited (Director, since 20 Feb 2026); Lyfine Pharma Private Limited (Director, since 07 Apr 2024).
Ruhani Singla was first appointed on 05 Mar 2024 as Director at Tyzpure Lifesciences Private Limited. The most recent appointment on record is 20 Feb 2026 at Kyzna Pharma Private Limited.
The current boards of Ruhani Singla's companies include Dharam Vir Singla (Tyzpure Lifesciences Private Limited), Shruti Jaryal (Kyzna Pharma Private Limited), Vivek Singla (Lyfine Pharma Private Limited).